Catena Biosciences
Innovating healthcare with unique protein fusion technology for advanced treatments in oncology, autoimmune disorders, and vaccines.
General Information
BounceWatch is an independent company data service, not affiliated with Catena Biosciences. To contact Catena Biosciences, visit catenabiosciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Catena Biosciences
Taxonomy: Biotech startup, Protein fusion technology, Oncology treatments, Autoimmune disorders, Vaccine development, Enzyme activation, UC Berkeley, Research-based innovation, Medical breakthroughs, Francis and Doudna labs, Innovative healthcare, Bioengineering, Therapeutic proteins
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | $2.35M | 7 |
|
10 May 2024 |
| Seed Round | Undisclosed | 1 |
|
11 May 2023 |
| Seed Round | $5.00M | 2 |
|
01 Aug 2021 |
| Pre Seed Round | $700.00K | - |
|
22 Apr 2021 |
Catena Biosciences Alternatives & Competitors
View All Alternatives
Enabling Intelligent Therapies with Multifunctional Biologics
AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne.
Our aim is to prevent life-threatening bacterial infections and combat antimicrobial resistance with...
FAQ About Catena Biosciences
Source: BounceWatch company record for Catena Biosciences, https://bouncewatch.com/company/catena-biosciences, updated 19 December 2024. When citing, please name BounceWatch and link this page.
